|
|
||||||||
Departments of 1 Diabetes and 2 Molecular Biology, Beckman Research Institute of the City of Hope, Duarte 91010; 4 Division of Nephrology, Harbor-UCLA Research and Education Institute, Torrance, California 90509; and 3 Department of Endocrinology, University of Virginia Medical School, Charlottesville, Virginia 22908
The lipoxygenase (LO) pathway of
arachidonate metabolism and mitogen-activated protein kinases (MAPKs)
can mediate cellular growth and ANG II effects in vascular smooth
muscle cells. However, their role in renal mesangial cells (MC) is not
very clear. ANG II treatment of rat MC significantly increased 12-LO
mRNA expression and formation of the 12-LO product
12(S)-hydroxyeicosatetraenoic acid [12(S)-HETE;
P < 0.03]. ANG II-induced [3H]leucine
incorporation was blocked by an LO inhibitor,
cinnamyl-3,4-dihydroxy-
-cyanocinnamate (P < 0.02).
12(S)-HETE and ANG II directly induced cellular hypertrophy and fibronectin (FN) expression (P < 0.01) to a
similar extent. ANG II and 12(S)-HETE led to activation of
p38MAPK and its target transcription factor cAMP-responsive
element-binding protein (CREB). ANG II- and
12(S)-HETE-induced CREB activation and
[3H]leucine incorporation were blocked by the
p38MAPK inhibitor SB-202190. A specific molecular inhibitor
of rat 12-LO mRNA, namely, a novel ribozyme, could attenuate ANG
II-induced FN mRNA. Thus p38MAPK-dependent CREB activation
may mediate ANG II- and LO product-induced FN expression and cellular
growth in rat MC. ANG II effects may be mediated by the LO pathway.
These results suggest a novel interaction between LO and
p38MAPK activation in MC matrix synthesis associated with
renal complications.
angiotensin II; 12(S)-hydroxyeicosatetraenoic acid; hypertrophy; p38MAPK; cAMP-responsive element-binding protein; fibronectin; rat
This article has been cited by other articles:
![]() |
Z.-G. Xu, L.-N. Miao, Y.-C. Cui, Y. Jia, H. Yuan, and M. Wu Angiotensin II type 1 receptor expression is increased via 12-lipoxygenase in high glucose-stimulated glomerular cells and type 2 diabetic glomeruli Nephrol. Dial. Transplant., June 1, 2009; 24(6): 1744 - 1752. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Abdel-Rahman, P. M. Abadir, and H. M. Siragy Regulation of renal 12(S)-hydroxyeicosatetraenoic acid in diabetes by angiotensin AT1 and AT2 receptors Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2008; 295(5): R1473 - R1478. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yuan, L. Lanting, Z.-G. Xu, S.-L. Li, P. Swiderski, S. Putta, M. Jonnalagadda, M. Kato, and R. Natarajan Effects of cholesterol-tagged small interfering RNAs targeting 12/15-lipoxygenase on parameters of diabetic nephropathy in a mouse model of type 1 diabetes Am J Physiol Renal Physiol, August 1, 2008; 295(2): F605 - F617. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-G. Xu, H. Yuan, L. Lanting, S.-L. Li, M. Wang, N. Shanmugam, M. Kato, S. G. Adler, M. A. Reddy, and R. Natarajan Products of 12/15-Lipoxygenase Upregulate the Angiotensin II Receptor J. Am. Soc. Nephrol., March 1, 2008; 19(3): 559 - 569. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Jalvy, M.-A. Renault, L. Lam Shang Leen, I. Belloc, A. Reynaud, A.-P. Gadeau, and C. Desgranges CREB Mediates UTP-Directed Arterial Smooth Muscle Cell Migration and Expression of the Chemotactic Protein Osteopontin via Its Interaction with Activator Protein-1 Sites Circ. Res., May 11, 2007; 100(9): 1292 - 1299. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. S. Kang, Y. G. Park, B. K. Kim, S. Y. Han, Y. H. Jee, K. H. Han, M. H. Lee, H. K. Song, D. R. Cha, S. W. Kang, et al. Angiotensin II stimulates the synthesis of vascular endothelial growth factor through the p38 mitogen activated protein kinase pathway in cultured mouse podocytes. J. Mol. Endocrinol., April 1, 2006; 36(2): 377 - 388. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. W. Reinhold, H. Vitzthum, T. Filbeck, K. Wolf, C. Lattas, G. A. J. Riegger, A. Kurtz, and B. K. Kramer Gene expression of 5-, 12-, and 15-lipoxygenases and leukotriene receptors along the rat nephron Am J Physiol Renal Physiol, April 1, 2006; 290(4): F864 - F872. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. R. Preston, N. S. Hill, R. R. Warburton, and B. L. Fanburg Role of 12-lipoxygenase in hypoxia-induced rat pulmonary artery smooth muscle cell proliferation Am J Physiol Lung Cell Mol Physiol, February 1, 2006; 290(2): L367 - L374. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-G. Xu, L. Lanting, N. D. Vaziri, Z. Li, L. Sepassi, B. Rodriguez-Iturbe, and R. Natarajan Upregulation of Angiotensin II Type 1 Receptor, Inflammatory Mediators, and Enzymes of Arachidonate Metabolism in Obese Zucker Rat Kidney: Reversal by Angiotensin II Type 1 Receptor Blockade Circulation, April 19, 2005; 111(15): 1962 - 1969. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-S. Kim, Z.-G. Xu, M. A. Reddy, S.-L. Li, L. Lanting, K. Sharma, S. G. Adler, and R. Natarajan Novel Interactions between TGF-{beta}1 Actions and the 12/15-Lipoxygenase Pathway in Mesangial Cells J. Am. Soc. Nephrol., February 1, 2005; 16(2): 352 - 362. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Stambe, R. C. Atkins, G. H. Tesch, T. Masaki, G. F. Schreiner, and D. J. Nikolic-Paterson The Role of p38{alpha} Mitogen-Activated Protein Kinase Activation in Renal Fibrosis J. Am. Soc. Nephrol., February 1, 2004; 15(2): 370 - 379. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Naito, T. Masaki, D. J. Nikolic-Paterson, C. Tanji, N. Yorioka, and N. Kohno Angiotensin II induces thrombospondin-1 production in human mesangial cells via p38 MAPK and JNK: a mechanism for activation of latent TGF-{beta}1 Am J Physiol Renal Physiol, February 1, 2004; 286(2): F278 - F287. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Yiu, X. Zhao, E. W. Inscho, and J. D. Imig 12-Hydroxyeicosatetraenoic acid participates in angiotensin II afferent arteriolar vasoconstriction by activating L-type calcium channels J. Lipid Res., December 1, 2003; 44(12): 2391 - 2399. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Reddy, Y.-S. Kim, L. Lanting, and R. Natarajan Reduced Growth Factor Responses in Vascular Smooth Muscle Cells Derived from 12/15-Lipoxygenase-Deficient Mice Hypertension, June 1, 2003; 41(6): 1294 - 1300. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |